Antigen receptor inputs: linking structural, molecular, and cellular responses
Antigen receptor inputs: linking structural, molecular, and cellular responses
批准号:
8318879
负责人:
JONATHAN P SCHNECK
金额:
$200.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2008
资助国家:
美国
项目状态:
已结题
起止时间:
2008-09-17 至 2014-08-31
关键词:
AddressAffectAnimal ModelAntigen ReceptorsAntigensArchitectureAreaAutoimmune ResponsesAutoimmunityBenefits and RisksBindingBiologicalBiological AssayBiophysicsBlinkingCD3 AntigensCD4 Positive T LymphocytesCalcium SignalingCell DeathCell modelCell surfaceCellsCessation of lifeCholesterolClone CellsCollaborationsComplexCuesCytoskeletonDevelopmentEngineeringEquilibriumEventGenesGeneticGenetic ScreeningGoalsImmune responseImmunologic SurveillanceIn VitroLateralLeadLigandsLinkLymphocyte ActivationMethodsMolecularMutateNF-kappa BOutcomeParasitesPathway interactionsPatternPeptide/MHC ComplexProcessProteinsQuantum DotsRegulationResearch PersonnelRoleScreening procedureSignal TransductionStimulusT cell anergyT cell responseT-Cell ActivationT-Cell ReceptorT-LymphocyteTechniquesTimeTranscriptional RegulationUniversitiesUrsidae FamilyVaccinesVirusWorkanergydesigngenetic manipulationglycosylationimmunological synapsein vivoinhibitor/antagonistinnovative technologiesmembermethod developmentnanoprobenanoscalenovelprogramsreceptorresponsesmall hairpin RNAtumor
中文摘要
描述(由申请人提供):本课程的首要目标是了解调节细胞激活的分子机制。通过对抗原的特异性识别激活淋巴细胞,其利益和风险的平衡非常有限,因此受到严格的调控。我们知道一些信号用于调节或终止激活,而其他信号诱导细胞无反应或死亡。具有不同结果的调控过程的分子机制是未知的,并且在很大程度上未定义。该计划包括五个高度互动的项目,涉及来自大学五个不同部门的六位研究人员。这些研究者为研究淋巴细胞活化及其调控问题带来了创新的技术和精辟的思路。这五个项目涵盖了一系列刺激、线索和结果,这些刺激、线索和结果导致T细胞激活或无反应的各种状态,从抗原识别的初始事件到转录的调节。这些项目涵盖了从纳米级分子相互作用到全细胞和动物模型的生物尺度。该计划涉及以下领域:1)TCR空间组织对T细胞反应的影响,2)免疫突触和T细胞能量的分子结构改变,3)作为T细胞激活的新型抑制剂的Sprouty 1, 4)通过TFII-I调节T细胞中的钙信号,5)通过TCR和共刺激信号调节NF-kB。这五个项目支持理解调节细胞活化的分子机制的总体目标。这个项目是在一个核心调查小组多年的互动中发展起来的,在过去的两年里,新同事加入了这个小组。调查人员之间的互动非常活跃。从详细的项目描述中可以明显看出小组成员之间协同作用的程度。我们想了解T细胞对抗原反应的机制。了解了这些机制,我们就能找到开启或关闭有益或有害的免疫反应的方法。
英文摘要
DESCRIPTION (provided by applicant): The overarching goal of this Program is to understand the molecular mechanisms that regulate cell activation. Activation of lymphocytes through specific recognition of antigen poses narrowly balanced benefits and risks, and hence is subject to tight regulation. We know that some signals serve to modulate or terminate activation, while other signals induce cell unresponsiveness or death. The molecular mechanisms underlying the regulatory processes with different outcomes are unknown and largely undefined. The Program consists of five highly interactive projects involving six investigators, from five different departments of the University. These investigators bring innovative technology and incisive ideas to bear on the problem of lymphocyte activation and its regulation. The five projects cover a range of stimuli, cues and outcomes that result in various states of T cell activation or unresponsiveness, from the initial events of antigen recognition to the regulation of transcription. The projects cover a biological scale from nano-scale molecular interactions to whole cell and animal models. The program addresses the following areas: 1) Influence of TCR spatial organization on T cell responses, 2) Altered molecular architecture at the Immunological Synapse and T cell anergy, 3) Sprouty 1 as a novel inhibitor of T cell activation, 4) Regulation of calcium signaling in T cells by TFII-I, 5) Regulation of NF-kB by TCR and costimulatory signaling. These five projects support the overall goal of understanding the molecular mechanisms regulating cell activation. The program has developed out of years of interaction among a core group of investigators who in the last two years have been joined by new colleagues. Interactions between investigators are flourishing. The extent of synergy between group members is apparent from the detailed project descriptions. We want to understand the mechanisms of T cell responses to antigen. Understanding these mechanisms will lead to ways of turning up, or turning off immune responses that are helpful or harmful.
PROJECT 1: The Influence of TCR spatial organization on T cell responses (PI [Schneck, Jonathan])
PROJECT 1 DESCRIPTION (provided by applicant): There is growing evidence that the clustering and spatial pattern of T cell receptors is critical for T cell responses. Changes in clustering and pattern can alter cell responsiveness from low to high, or even to unresponsive. We aim to investigate the genetics and the biophysics of T cell receptor clustering and pattern. Genetic screens will be used to identify pathways that are important for the enhanced clustering of T cell receptors found on activated T cells. We will use an shRNA screen to focus on pathways known to affect T cell receptor clustering -glycosylation and the role of cholesterol and its interaction with the cytoskeleton. Second we will analyze the impact of genes identified in the screen in binding of a TCR ligand, soluble peptide-MHC-lg complexes to T cells and in vitro and in vivo T cell responses. In addition we will engineer quantum dots that will present TCR ligands, MHC/peptide or anti-CD3 to naive and activated T cells. The quantum dots will be used to probe the lateral organization of TCR on naive and activated T cells. Blinking of bound quantum dots will be analyzed quantitatively to follow changes in receptor organization with time.
Synergies with other projects: A specific aim of Project 2, is to analyze the TCR organization and SMAC formation in activated CD4 cells. Project 1's work on the genetic control of TCR clustering will be directly relevant to that project. Also, the nanoprobes and methods for characterizing TCR organization of this project will be used to probe the nano-organization of TCR on naive or activated CD4+ cells. In Project 3 quantum dots will be used to characterize changes in TCR clustering during induction of anergy in vivo. Quantum dots and genetic manipulation will also be used in collaboration with Dr. Desiderio's Project 4 to characterize T cell receptor states in cells and clones lacking TFII-I or carrying a mutated form of the protein. There has already been strong interaction with Project 5 in designing selection/screening assays for genetic control of TCR clustering. In addition using the techniques developed in Specific Aim 1 we will analyze the effects of the genes identified in Project 5 on TCR clustering.
Many immune responses, for example responses to parasites, to tumors and to some viruses, are often blunted because T cells respond to antigen by turning off, rather than by activating and attacking their targets. Understanding the arrangement of T cell antigen receptors that is most likely to trigger T cells, will lead to development of methods to manipulate the T cell surface to produce a strong, focused response, or, to suppress response, rearranging the receptors to limit autoimmune responses.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1371/journal.pone.0121710
发表时间:
2015
期刊:
PloS one
影响因子:
3.7
作者:
[Pollizzi KN, Waickman AT, Patel CH, Sun IH, Powell JD]
通讯作者:
Powell JD
Selective activation of antigen-experienced T cells by anti-CD3 constrained on nanoparticles.
抗CD3限制了纳米颗粒的抗CD3对抗原经验的T细胞的选择性激活。
DOI:
10.4049/jimmunol.1301433
发表时间:
2013-11-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Lo YC, Edidin MA, Powell JD]
通讯作者:
Powell JD
DOI:
10.4049/jimmunol.1601318
发表时间:
2017-02-01
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
[Bettencourt IA, Powell JD]
通讯作者:
Powell JD
A high fat diet containing saturated but not unsaturated fatty acids enhances T cell receptor clustering on the nanoscale.
含有饱和脂肪酸但不含有不饱和脂肪酸的高脂肪饮食可以增强纳米级 T 细胞受体的聚集。
DOI:
10.1016/j.plefa.2015.05.001
发表时间:
2015
期刊:
Prostaglandins, leukotrienes, and essential fatty acids
影响因子:
--
作者:
[Shaikh,SaameRaza, Boyle,Sarah, Edidin,Michael]
通讯作者:
Edidin,Michael
DOI:
10.1186/s13569-018-0107-9
发表时间:
2018
期刊:
Clinical sarcoma research
影响因子:
--
作者:
[Trucco MM, Meyer CF, Thornton KA, Shah P, Chen AR, Wilky BA, Carrera-Haro MA, Boyer LC, Ferreira MF, Shafique U, Powell JD, Loeb DM]
通讯作者:
Loeb DM
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells
-
批准号:10167008
-
项目类别:
-
资助金额:$16.38万
-
财政年份:2020
-
负责人:JONATHAN P SCHNECK
-
依托单位:
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
-
批准号:10436868
-
项目类别:
-
资助金额:$116.72万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
-
批准号:10645127
-
项目类别:
-
资助金额:$31.68万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
JH-TIE Admin Core
-
批准号:10436869
-
项目类别:
-
资助金额:$10.63万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
-
批准号:10017988
-
项目类别:
-
资助金额:$117.37万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
JH-TIE Admin Core
-
批准号:10223292
-
项目类别:
-
资助金额:$10.58万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
-
批准号:10645124
-
项目类别:
-
资助金额:$115.98万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
JH-TIE Admin Core
-
批准号:9790436
-
项目类别:
-
资助金额:$61.37万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
-
批准号:10223293
-
项目类别:
-
资助金额:$31.12万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
A high-throughput nanoparticle assay to characterize cancer neoepitope-specific T cells
-
批准号:9916739
-
项目类别:
-
资助金额:$40.05万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
-
批准号:9790435
-
项目类别:
-
资助金额:$170.74万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
The Johns Hopkins Translational ImmunoEngineering (JH-TIE) BTRC
-
批准号:10223291
-
项目类别:
-
资助金额:$115.03万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
-
批准号:10436870
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
JH-TIE Admin Core
-
批准号:10645125
-
项目类别:
-
资助金额:$10.63万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
TR&D1: Engineering artificial Antigen Presenting Cells, aAPC, for Adoptive Immunotherapy
-
批准号:9790437
-
项目类别:
-
资助金额:$31.76万
-
财政年份:2019
-
负责人:JONATHAN P SCHNECK
-
依托单位:
Antigen receptor inputs: linking structural, molecular, and cellular responses
-
批准号:7868850
-
项目类别:
-
资助金额:$35.55万
-
财政年份:2009
-
负责人:JONATHAN P SCHNECK
-
依托单位:
Antigen receptor inputs: linking structural, molecular, and cellular responses
-
批准号:7914320
-
项目类别:
-
资助金额:$201.98万
-
财政年份:2008
-
负责人:JONATHAN P SCHNECK
-
依托单位:
Antigen receptor inputs: linking structural, molecular, and cellular responses
-
批准号:7687424
-
项目类别:
-
资助金额:$198.21万
-
财政年份:2008
-
负责人:JONATHAN P SCHNECK
-
依托单位:
Antigen receptor inputs: linking structural, molecular, and cellular responses
-
批准号:8137710
-
项目类别:
-
资助金额:$200.75万
-
财政年份:2008
-
负责人:JONATHAN P SCHNECK
-
依托单位:
Profiling of influenza-specific immune responses in the elderly
-
批准号:7393029
-
项目类别:
-
资助金额:$24.58万
-
财政年份:2007
-
负责人:JONATHAN P SCHNECK
-
依托单位:
海外基金